Benzinga
Benzinga
Benzinga
jeudi, octobre 01

Merck & Co Inc

MRKNYSE
Trade with Public
Trade with Public
$145.31
-3.97-2.66%
À la clôture: Sep 30, 5:00 PM EST
$145.31
0.00030%
Après les heures: 7:47 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatDividendesComparerOptionsRapport sur les stocks

Merck & Co Analyst Price Targets

Wall Street analyst price targets and consensus rating for Merck & Co (MRK).

Price Target Range — 10 Quarters

Analyst Consensus — 24 Analysts

15Buy
9Hold
Consensus RatingBuy# Analysts24Avg. Consensus PT$143Upside to Avg. PT-1.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →
DateFirmAnalystActionRating ChangePrice Target
Sep 29, 2026ScotiabankLouise ChenPT RaiseSector Outperform$155→$180
Sep 10, 2026HSBCRajesh KumarPT RaiseBuy$150→$172
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Scotiabank Maintains Sector Outperform on Merck & Co, Raises Price Target to $180

Scotiabank analyst Louise Chen maintains Merck & Co (NYSE:MRK) with a Sector Outperform and raises the price target from $155 to $180.
Benzinga Newsdesk

PRO
HSBC Maintains Buy on Merck & Co, Raises Price Target to $172

HSBC analyst Rajesh Kumar maintains Merck & Co (NYSE:MRK) with a Buy and raises the price target from $150 to $172.
Benzinga Newsdesk

PRO
Leerink Partners Maintains Outperform on Merck & Co, Raises Price Target to $161

Leerink Partners analyst Daina Graybosch maintains Merck & Co (NYSE:MRK) with a Outperform and raises the price target from $127 to $161.
Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Merck & Co, Raises Price Target to $170

Guggenheim analyst Vamil Divan maintains Merck & Co (NYSE:MRK) with a Buy and raises the price target from $146 to $170.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Merck & Co, Raises Price Target to $170

Wells Fargo analyst Mohit Bansal maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $150 to $170.
Benzinga Newsdesk

PRO
Wolfe Research Maintains Outperform on Merck & Co, Raises Price Target to $180

Wolfe Research analyst Alexandria Hammond maintains Merck & Co (NYSE:MRK) with a Outperform and raises the price target from $155 to $180.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved